Side Effects Involving the Heart in Women With Breast Cancer Receiving Doxorubicin and Trastuzumab

NCT00875238 · clinicaltrials.gov ↗

COMPLETED

Status

133

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer
Cardiac Toxicity
Cardiovascular Complications

Interventions

BIOLOGICAL: trastuzumab
DRUG: doxorubicin hydrochloride
GENETIC: polymorphism analysis
OTHER: laboratory biomarker analysis
OTHER: questionnaire administration
PROCEDURE: assessment of therapy complications
PROCEDURE: magnetic resonance imaging

Sponsor

Vanderbilt University

Collaborators

[object Object]